Home
Medicines
Companies
COVID-19
Active Ingredients
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Companies
COVID-19
More
expand_more
Login
menu
Home
Active Ingredients
Lanadelumab
Lanadelumab
Medicine
Status
PIL
SPC
XPIL
EDM - Patient
EDM - HCP
Legal Category
Active Ingredient(s)
Company
TAKHZYRO 300 mg solution for injection in pre-filled syringe
Updated
PIL
13/10/21
SPC
13/10/21
No
-
-
A
Lanadelumab
Takeda Products Ireland Ltd
Documents associated with this medicine were updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
